RESUMO
Infective endocarditis (IE) is rare, but associated with significant morbidity and mortality rates. Estimates of the incidence of IE in Turkey are compromised by the absence of population-based prospective studies. Due to the frequent presence of predisposing cardiac conditions and higher rates of nosocomial bacteremia in highrisk groups, the incidence of IE is expected to be higher in Turkey. Additionally, while IE generally affects older people in developed countries, it still affects young people in Turkey. In order to reduce the mortality and morbidity, it is critical to diagnose the IE to determine the causative agent and to start treatment rapidly. However, most of the patients cannot be diagnosed in their first visits, about half of them can be diagnosed after three months, and the disease often goes unnoticed. In patients diagnosed with IE, the rate of identification of causative organisms is significantly lower in Turkey than in developed countries. Furthermore, most of the centers do not perform some essential microbiological diagnostic tests as a routine practice. Some antimicrobials that are recommended as the first-line of treatment for IE, particularly antistaphylococcal penicillins, are not available in Turkey. These problems necessitate reviewing the epidemiological, laboratory, and clinical characteristics of IE in our country, as well as the current information about its diagnosis, treatment, and prevention together with local data. Physicians can follow patients with IE in many specialties. Diagnosis and treatment processes of IE should be standardized at every stage so that management of IE, a setting in which many physicians are involved, can always be in line with current recommendations. Study Group for Infective Endocarditis and Other Cardiovascular Infections of the Turkish Society of Clinical Microbiology and Infectious Diseases has called for collaboration of the relevant specialist organizations to establish a consensus report on the diagnosis, treatment, and prevention of IE in the light of current information and local data in Turkey.
RESUMO
Objetivo: este estudo investigou a incidência da adesão de Candida albicans e Staphylococcus aureus em próteses superiores obturadoras com materiais de reembasamento macio utilizados por protesistas. Material e Métodos: entre os anos 2013 e 2014, foram avaliados clinicamente, pacientes com defeitos maxilares devido a cirurgia para remoção de tumores e usuários de próteses obturadoras (n = 21, grupo de estudo) e, as consequências microbiológicas foram comparadas com usuários de prótese total superior (n = 21, controle grupo). Os dados foram coletados sobre características demográficas, tipo histológico de câncer, emprego de quimioterapia ou radioterapia, identificação dos materiais reembasamento macio utilizados e métodos de limpeza praticados nas próteses obturadoras e totais. A presença de Candida albicans foi determinada nos materiais de reembasamento macio ou nas superfícies de polimetilmetacrilato e na cavidade bucal e, Staphylococcus aureus na mucosa nasal e na saliva. Os dados foram analisados utilizando os testes Kruskal Wallis, Fisher-Freeman-Halton (p<0,05). Resultados: A maior quantidade de Candida albicans foi encontrada nas superfícies das próteses, na saliva, nos defeitos no palato duro e no material de reembasamento macio definitivo com 90%, 90% e 70%, respectivamente. A maior quantidade de Staphylococcus aureus foi observada na saliva e na cavidade nasal no grupo de material de reembasamento macio definitivo (50%). Conclusão: o curto período de renovação dos materiais de revestimento pode causar menos colonização de Candida albicans e estomatite protética na cavidade bucal. Os pacientes que sofreram maxilectomia foram mais propensos à colonização de Staphylococcus aureus.(AU)
Objective: This study investigated on the incidence of Candida albicans and Staphylococcus aureus adhesion onto maxillary obturator prostheses with soft lining materials placed by prosthodontists. Material and Methods: Between years 2013 and 2014, patients with maxillary defects due to maxillary tumor surgery and acquired obturator prostheses (n = 21, study group) were clinically evaluated and microbiological outcomes were compared with complete maxillary denture wearers (n = 21, control group). Data were collected on demographic features, histological type of cancer, presence of chemotherapy or radiotherapy, identification of soft lining materials used on obturator prostheses, cleansing methods practiced for obturator and maxillary complete prostheses. The presence of Candida albicans was determined on soft lining materials or polymethylmethacrylate surfaces and in the oral cavity, and Staphylococcus aureus in nasal mucosa and saliva. Data were analyzed using Kruskal Wallis, Fisher-Freeman-Halton tests (p<0.05). Results: The highest amount of Candida albicans was found on surfaces of prostheses, in the saliva and on maxillary defects on the hard palate and on definitive soft lining material with 90%, 90%, and 70%, respectively. The highest amount of Staphylococcus aureus was observed in the saliva and nasal cavity in the definitive soft lining material group (50%). Conclusion: Short renewal period of lining materials may cause less Candida albicans colonisation and denture stomatitis in the oral cavity. Patients who have undergone maxillectomy were more prone to Staphylococcus aureus colonisation.(AU)